Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease

Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death

Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691

Staging of brain pathology related to sporadic Parkinson’s disease

Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777

Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672

Astrocyte-endothelial interactions at the blood-brain barrier

Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595

Structure and function of the blood–brain barrier

Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185

Microglia-mediated neurotoxicity: uncovering the molecular mechanisms

Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110

Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1

Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481

Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990

Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism

Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C. J., Squitieri, F., Ibáñez, P., Joosse, M., et al. (2003) · Science · doi:10.1126/science.1077209 · Cited by 2,854

Synthetic neuromelanin as a trigger of inflammation in the brain – new mouse model of Parkinson’s diseasePreprint

Tejchman, A., Strzelec, M., Kot, M., Chlebanowska, P., Badyra, B., Sobocińska, M. K., Zecca, L., & Majka, M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.28.538536 · Cited by 4

Locus coeruleus neuromelanin accumulation and dissipation across the lifespanPreprint

Riley, E., Cicero, N. G., Swallow, K. M., Rosa, E. D., & Anderson, A. K. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.17.562814 · Cited by 6

Bioactive compounds from marine macroalgae in the treatment and prevention of neurodegenerative diseases

Leal, M. F. C., Duarte, R. J. G., Cardoso, I. L., Catarino, R. I. L., Pimenta, A. M., & Souto, M. R. S. (2023) · Neurophysiology · doi:10.1007/s11062-025-09953-1 · Cited by 3

Combination Supplement Therapy: A New Frontier in Treatment of Neurodegenerative Diseases

Shtilbans, A. (2025) · Journal of Nutrition · doi:10.1016/j.tjnut.2025.07.004 · Cited by 3

Technical Feasibility of Quantitative Susceptibility Mapping Radiomics for Predicting Deep Brain Stimulation Outcomes in Parkinson Disease

Roberts, A., Zhang, J., Tozlu, C., Romano, D., Akkuş, S., Kim, H., Sabuncu, M. R., Spincemaille, P., Li, J., Wang, Y., et al. (2025) · Neurosurgery · doi:10.1227/neu.0000000000003721 · Cited by 3

Therapeutic potential of KATP channels in the attenuation of Parkinson's disease pathogenesis and progression – A review

Gundi, B., Ho, H. L., Zhang, X., He, A., Xin, D., Ferreira, A. F. F., de Britto, L. R. G., Feng, Z., & Sun, H. (2025) · Neurochemistry International · doi:10.1016/j.neuint.2025.106091 · Cited by 3

The locus coeruleus, a blue spot for early diagnosis and prognosis of Alzheimer’s disease

Farahani, F., Anaclet, C., Azizi, H., & Gompf, H. S. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1632236 · Cited by 4

OCT-based retinal biomarkers forecast central nervous system structural decline in Parkinson’s disease: A longitudinal multimodal study within the Persian Cohort

Nikparast, F., Sharak, N. A., Ganji, Z., Shoeibi, A., Shoeibi, N., & Zare, H. (2025) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2025.105310 · Cited by 3

Gray Matter Iron and Neuromelanin in Psychosis: A Systematic Review and Meta-Analysis of MRI Studies

Vano, L. J., Sedlacik, J., Carr, R. W., Bukala, B. R., Howes, O. D., & McCutcheon, R. (2026) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20251257 · Cited by 3

Bidentate Metal-Binding Motifs in US FDA Approved Small Molecule Drugs

Njardarson, J. T., & Tomat, E. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c01319 · Cited by 3

Mechanisms of Dopamine Oxidation and Parkinson’s Disease

Segura‐Aguilar, J., & Paris, I. B. (2022) · Springer eBooks · doi:10.1007/978-3-031-15080-7_16 · Cited by 3

Neurovascular unit impairment in iron deficiency anemia

Isasi, E., & Olivera‐Bravo, S. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.12.050 · Cited by 4

Exploring the Relationship between Parkinson’s Disease and Restless Legs Syndrome

López‐Jiménez, A., Anguizola, D., Aragón, A. G., Moncada, B., de Noël, A. C. A., & Garcı́a-Borreguero, D. (2025) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2025.05.001 · Cited by 3

Blood oxygenation level-dependent responses in neuromodulatory nuclei and their associations with attention and memory across age groups

Riley, E., Cicero, N. G., Swallow, K. M., Anderson, A. K., & Rosa, E. D. (2025) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2025.07.010 · Cited by 4

CRISPR /Cas9‐Based Functional Genomics in Human Induced Pluripotent Stem Cell–Derived Models: Can “the Stars Align” for Neurodegenerative Diseases?

Chen, Y., Jong, T., Chen, C., & Sidransky, E. (2022) · Movement Disorders · doi:10.1002/mds.28998 · Cited by 3

Multivariate and regional age-related change in basal ganglia iron in neonates

Cabral, L. M., Calabro, F. J., Foran, W., Parr, A. C., Ojha, A., Rasmussen, J. M., Ceschin, R. C., Panigrahy, A., & Luna, B. (2023) · Cerebral Cortex · doi:10.1093/cercor/bhad456 · Cited by 3

Adenosine Receptors and Neuroinflammation

Ferrante, A., Simone, R. D., Ajmone‐Cat, M. A., Minghetti, L., & Popoli, P. (2018) · Springer eBooks · doi:10.1007/978-3-319-90808-3_9 · Cited by 3

From Superficial Damage to Invasion of the Nucleosome: Ranking of Morbidities by the Biosemiotic Depth Hypothesis

Oller, J. W., & Shaw, C. A. (2019) · International Journal of Sciences · doi:10.18483/ijsci.2069 · Cited by 6

Stratification of the Type 2 Diabetes Mellitus Based on Heart Rate Variability Parameters in Elderly Women at Rest

Materko, W., Fernandes, D. F., & Pena, F. P. D. S. (2020) · Journal of Biomedical Engineering and Medical Imaging · doi:10.14738/jbemi.73.8369 · Cited by 3

Adult Endogenous Dopaminergic Neuroregeneration Against Parkinson’s Disease: Ideal Animal Models?

Vijayanathan, Y., Lim, S. M., Tan, M. P., Lim, F. T., Majeed, A. B. A., & Ramasamy, K. (2020) · Neurotoxicity Research · doi:10.1007/s12640-020-00298-7 · Cited by 4

Visualizing alpha-synuclein and iron deposition in M83 mouse model of Parkinson’s disease in vivoPreprint

Straumann, N., Combes, B. F., Deán‐Ben, X. L., Sternke‐Hoffmann, R., Gerez, J., Dias, I., Chen, Z., Watts, B., Rostami, I., Shi, K., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.28.546962 · Cited by 3

Grey Matter Iron and Neuromelanin in Psychosis: A Systematic Review and Meta-Analysis of MRI StudiesPreprint

Vano, L. J., Sedlacik, J., Carr, R. W., Bukala, B. R., Howes, O. D., & McCutcheon, R. A. (2026) · medRxiv · doi:10.64898/2026.01.15.26344182 · Cited by 3

Evidence for Dopamine Abnormalities Following Acute Methamphetamine Exposure Assessed by Neuromelanin-Sensitive Magnetic Resonance Imaging

Tang, F., Liu, H., Zhang, X. J., Zheng, H., Dai, Y. M., Zheng, L. Y., Yang, W. H., Du, Y. Y., & Liu, J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.865825 · Cited by 2

Iron and neuromelanin imaging in basal ganglia circuitry in Parkinson's disease with freezing of gait

Zhang, Y., Zhang, C., Wang, X., Liu, Y., Jin, Z., Haacke, E. M., He, N., Li, D., & Yan, F. (2024) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2024.05.011 · Cited by 2

Indirect Spectrophotometric Determination of Antidepressant Drugs by Oxidation Using Ponceau 4R Dye

Abbas, A. H., Al-Mtwaiti, S. M. J., & Sabh, T. N. A. (2024) · Pakistan Journal of Analytical & Environmental Chemistry · doi:10.21743/pjaec/2024.06.11 · Cited by 2

Dopamine Toxicity Induces ROS-Dependent Death of Murine Neuroblastoma Cells: Impact on the Interactions of Cofilin With UCHL1 and MMP9

Roy, T., Banerjee, R., Chatterjee, A., & Swarnakar, S. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04362-6 · Cited by 2

Dual Role of Exosomes in Parkinson's Disease: Adenine Exerts a Beneficial Effect

Chen, L., Shao, Y., Geng, J., Liu, H., Liu, Q., Cheng, Y., & Sun, T. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70331 · Cited by 2

Diagnostic Potential of Macromolecular Proton Fraction Mapping Combined with Quantitative Susceptibility Mapping as a Subcortical Biomarker for Parkinson’s Disease

Fujiwara, Y., Sakae, N., Kumazoe, H., Miyamoto, K., Hirakawa, Y., Kan, H., Yamashita, K., & Kitajima, M. (2025) · Magnetic Resonance in Medical Sciences · doi:10.2463/mrms.mp.2025-0045 · Cited by 2

Metabolic Parkinson’s disease

Invernizzi, F., Ciocca, L., Contaldi, E., Inverso, D., Calandrella, D., Mignone, F., Barichella, M., Isaias, I. U., & Pezzoli, G. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1665957 · Cited by 3

Spatiotemporal nigrostriatal iron accumulation in motor subtypes of Parkinson’s disease: from early to late stage

Bu, S., Pang, H., Li, X., Liu, Y., Zhao, M., Wang, J., Huang, L., Niu, Q., Liang, L., Yu, H., et al. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf473 · Cited by 2

Rising Stars: In vivo Monitoring of Neurochemical Dynamics by Genetically Encoded Neuromodulator Sensors

Fu, S., & Li, Y. (2026) · Journal of Molecular Biology · doi:10.1016/j.jmb.2026.169669 · Cited by 2

From Stress to Neurodegeneration: A New Look at the Pathogenesis of Parkinson’s Disease

Kazanskaya, R. B., Tsytsarev, V., Volnova, A. B., Gainetdinov, R. R., & Lopachev, A. V. (2026) · Biomedicines · doi:10.3390/biomedicines14051130 · Cited by 2

Detecting parkinsonian degeneration in lateroventral tier of substantia nigra pars compacta with MRI

Langley, J. A., Huddleston, D. E., & Hu, X. P. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815950-7.00020-5 · Cited by 2

Mechanisms of Dopamine Oxidation and Parkinson’s Disease

Segura‐Aguilar, J., & Paris, I. B. (2022) · Springer eBooks · doi:10.1007/978-3-030-71519-9_16-1 · Cited by 2

Computational design of rasagiline derivatives: Searching for enhanced antioxidant capability

Reina, M., Guzmán‐López, E. G., & Galano, A. (2022) · International Journal of Quantum Chemistry · doi:10.1002/qua.27011 · Cited by 3

Neuroimaging Human Dopamine-Related Neurophysiology Across Development

Parr, A. C., Larsen, B., Calabro, F. J., Tervo‐Clemmens, B., & Luna, B. (2022) · Neuromethods · doi:10.1007/978-1-0716-2799-0_13 · Cited by 2

Comparative Evaluation of the Asymmetric Synthesis of (S)-Norlaudanosoline in a Two-Step Biocatalytic Reaction with Whole Escherichia coli Cells in Batch and Continuous Flow Catalysis

Arnold, A. H., & Castiglione, K. (2023) · Catalysts · doi:10.3390/catal13101347 · Cited by 2

Mapping internal brainstem structures using T1 and T2 weighted 3T images

Mueller, S. G. (2023) · Frontiers in Neuroimaging · doi:10.3389/fnimg.2023.1324107 · Cited by 2

Multiple Demographic, Lifestyle, and Biological Factors Associated With Brain Iron Deposition in the Basal Ganglia: A Comprehensive Analysis of 25,980 UK Biobank Participants

Liang, P., Yang, L., Chen, Y., Cheng, Z., Gao, Y., Sui, C., Zhang, X., Wang, N., Wang, Y., Liang, C., et al. (2025) · Brain and Behavior · doi:10.1002/brb3.70862 · Cited by 1

An unexpected iron in the fire of speech production

Sommer, M., SheikhBahaei, S., & Maguire, G. A. (2021) · Brain · doi:10.1093/brain/awab348 · Cited by 2

Neuromelanin accumulation in Substantia nigra in vascular parkinsonism

Mantese, C. E. A., & Hainzenreder, T. B. (2020) · Journal of Neural Transmission · doi:10.1007/s00702-020-02191-1 · Cited by 2

Dopamine and L-Dopa as Selective Endogenous Neurotoxins

Segura‐Aguilar, J., Ahumada-Castro, U., & Paris, I. B. (2022) · Springer eBooks · doi:10.1007/978-3-031-15080-7_70 · Cited by 2

Crocin Protects Malathion-induced Parkinson-like Disease by Inhibiting Apoptosis and α-synuclein Accumulation in Rats’ StriatumPreprint

Mohammadzadeh, L., Rahbardar, M. G., Razavi, B. M., & Hosseinzadeh, H. (2021) · Research Square · doi:10.21203/rs.3.rs-1028580/v1 · Cited by 2

Discovery of a Gut Bacterial Metabolic Pathway that Drives α-Synuclein Aggregation and NeurodegenerationPreprint

de Ora, L. O., Uyeda, K. S., & Bess, E. N. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.08.495350 · Cited by 2

Adolescent neurocognitive development

Ravindranath, O., Parr, A. C., Perica, M. I., Elliott, S., & Luna, B. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-818872-9.00105-9 · Cited by 4

Maturation of striatal dopamine supports the development of habitual behavior through adolescencePreprint

Petrie, D. J., Parr, A. C., Sydnor, V. J., Ojha, A., Foran, W., Tervo‐Clemmens, B., Calabro, F. J., & Luna, B. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.06.631527 · Cited by 3

Clinical and pathological features of brain iron metabolism in neurodegerative and demyelinating disorders

Dynin, P. S., Litvinenko, I., Emelin, А. Y., & Ruban, A. V. (2023) · Russian Military Medical Academy Reports · doi:10.17816/rmmar609500 · Cited by 1

Quantitative changes in ferritin-containing glia in the structures of the substantia nigra in aging and Parkinson’s disease

Николаевич, С. В., Воронков, Д. Н., & Sukhorukov, V. S. (2024) · CLINICAL AND EXPERIMENTAL MORPHOLOGY · doi:10.31088/cem2024.13.2.20-25 · Cited by 1

Prefrontal cortex iron content in neurodegeneration and healthy subjects: A systematic review

Mohammadi, S., Ghaderi, S., Pourasl, M. H., & Fatehi, F. (2025) · Ibrain · doi:10.1002/ibra.12195 · Cited by 1

Unlocking molecular secrets: The role of miRNAs in Parkinson's disease dynamics

Abdelhamid, R., Abobakr, M., Mohamed, M., Hussieny, A., Mohamed, A., tarek, M., & Elshaer, S. S. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110542 · Cited by 1

Deep learning-based MRI segmentation for substantia nigra in Parkinson's disease with cognitive impairment

Qi, W., Wang, J., Yang, Z., Cheng, J., Niu, X., Shao, N., Ren, Y., 何建行, Li, H., & Li, H. (2026) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2026.108260 · Cited by 1

Semi-Automated Neuromelanin-Sensitive MRI Reveals Substantia Nigra Volume Reduction in Early Parkinson’s Disease with Moderate Diagnostic Performance

Silovs, A., Šķuburs, G. K., Zdanovskis, N., Aleksejs, Š., Mednieks, J., Naudiņš, E., Bartušēvica, S., Umbraško, S., Zarina, L., Zelge, L., et al. (2026) · Diagnostics · doi:10.3390/diagnostics16071046 · Cited by 1

Combination Disease‐Modifying Therapy for Neurodegenerative Diseases Using Repurposed Drugs

Shtilbans, A., & Lang, A. E. (2026) · Annals of Neurology · doi:10.1002/ana.78190 · Cited by 1

A frontotemporal dementia–like phenotype in schizophrenia: links to striatal dopamine and iron accumulation

Chang, X., Bryant, L., Mena, S., Howes, O. D., Sedlacik, J., Veronese, M., Schroeter, M. L., Lalousis, P. A., Koutsouleris, N., Vano, L. J., et al. (2026) · Neuropsychopharmacology · doi:10.1038/s41386-026-02426-x · Cited by 1

Reimagining the contribution of iron in Parkinson's disease

Serpa, R. O., Tufano, E., & Connor, J. R. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107434 · Cited by 1

Developmental variation in basal ganglia tissue iron, neurocognitive functioning, and impulsivity is associated with substance use trajectories in youth

Parr, A. C., Ojha, A., Petrie, D. J., Calabro, F. J., Tervo‐Clemmens, B., Foran, W., Fitzgerald, D., Tapert, S. F., Nooner, K. B., Thompson, W., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-73611-1 · Cited by 4

Bioinformatics identification of forkhead box O3 and the proto-oncogene tyrosine-protein kinase receptor RET as aging-associated biomarkers linked to immune cell infiltration in Parkinson’s disease

Zheng, H., Guan, A., Li, X., Zhang, X., Zheng, L., & Zhao, Y. (2026) · CytoJournal · doi:10.25259/cytojournal_127_2025 · Cited by 1

Levodopa and Melanoma: Practical Recommendations for Parkinson's Disease—International Parkinson and Movement Disorder Society Scientific Issues Committee Viewpoint

Sciacca, G., Elsayed, I., Perez‐Lloret, S., Outeiro, T. F., Unni, V. K., Kordower, J. H., Berg, D., & Kalia, L. V. (2026) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.70775 · Cited by 1

Melatonin: A versatile neuroprotective molecule in neurodegenerative diseases: A narrative review

Jazi, A. A., Yousefi, S., Reiter, R. J., Mojaveraghili, S. B., Amirkhanlou, S., Yekani, M., Farzanegan, S., Mir, S. M., & Memar, M. Y. (2026) · Tissue and Cell · doi:10.1016/j.tice.2026.103884 · Cited by 1

An Improved Biocompatible Probe for Photoacoustic Tumor Imaging Based on the Conjugation of Melanin to Bovine Serum Albumin

Capozza, M., Stefanìa, R., Rosas, L., Arena, F., Consolino, L., Anemone, A., Cimino, J. J., Longo, D. L., & Aime, S. (2020) · Applied Sciences · doi:10.3390/app10238313 · Cited by 1

Label‐Free Nanoimaging of Neuromelanin in the Brain by Soft X‐ray Spectromicroscopy

Brooks, J., Everett, J. L., Lermyte, F., Tjhin, V. T., Banerjee, S., O’Connor, P. B., Morris, C. M., Sadler, P. J., Telling, N. D., & Collingwood, J. F. (2020) · Angewandte Chemie · doi:10.1002/ange.202000239 · Cited by 1

Melanins☆

Naoi, M., Maruyama, W., & Riederer, P. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.00667-2 · Cited by 2

Relationship between Febrile Seizures and Iron Deficiency Anemia in Children

Kadhem, R. H., & Tarish, A. K. (2022) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2022.9820 · Cited by 1

Role of bioactive substances in sheep's milk and its products in the prevention of neurodegenerative diseases

Flis, Z., & Molik, E. (2023) · Medycyna Weterynaryjna · doi:10.21521/mw.6796 · Cited by 1

Enigmatic secondary metabolites: Microbial melanins and their applications

Narang, U., Kurian, N. K., & Bayram, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95241-5.00017-4 · Cited by 1

Large-scale functional network connectivity mediates the association between nigral neuromelanin hypopigmentation and motor impairment in Parkinson’s disease

Su, Y., Lu, J., Li, Y., Zhu, H., Tian, T., Qin, Y., & Zhu, W. (2024) · Brain Structure and Function · doi:10.1007/s00429-024-02761-z · Cited by 1

In vitro multiple pharmacological targets of Colutea cilicica Boiss. & Balansa against key enzymes linked to neurodegenerative diseases, diabetes, and hyperpigmentation

Uysal, Ş., Ceylan, R., Aktümsek, A., Güler, G. Ö., & Picot, C. M. N. (2019) · Istanbul Journal of Pharmacy · doi:10.5152/istanbuljpharm.2018.396764 · Cited by 1

Dermatological Applications of EPR: Skin-Deep or In-Depth?

Krzykawska-Serda, M., Michalczyk‐Wetula, D., & Plonka, P. M. (2018) · Springer eBooks · doi:10.1007/978-981-13-2230-3_8 · Cited by 1

Multiscale X-Ray Analysis of Biological Cells and Tissues by Scanning Diffraction and Coherent Imaging

Nicolas, J. (2019) · Göttingen series in x-ray physics · doi:10.17875/gup2019-1178 · Cited by 1

Mobility Deficits Assessed With Mobile Technology: What Can We Learn From Brain Iron-Altered Animal Models?

Hopfner, F., Hobert, M. A., Maetzler, C., Hansen, C., Pham, M. H., Moreau, C., Berg, D., Devos, D., Maetzler, W., & The Fair-Park II study group (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00833 · Cited by 1

Three-Dimensional Holey-graphene for Simultaneous Sensing in Biological Fluids

Jing, A., Qiong, X., Feng, W., & Liang, G. (2019) · International Journal of Electrochemical Science · doi:10.20964/2019.10.32 · Cited by 1

Iron

Kezele, T. G. (2018) · Healthy ageing and longevity · doi:10.1007/978-3-030-03742-0_1 · Cited by 1

Water‐Soluble Melanin–Protein–Fe/Cu Conjugates Derived from Norepinephrine as Reliable Models for Neuromelanin of Human Brain Locus Coeruleus

Capucciati, A., Monzani, E., Sturini, M., Nicolis, S., Zucca, F. A., Bubacco, L., Bortolus, M., Zecca, L., & Casella, L. (2022) · Angewandte Chemie · doi:10.1002/ange.202204787 · Cited by 1

Changes in the expression of TRPV4 and TRPM8 channels in the colon of rats with 6-OHDA-induced Parkinson’s disease

Стецька, В. О., Dovbynchuk, T., Dziubenko, N., Zholos, A. V., & Tolstanova, G. M. (2022) · The Ukrainian Biochemical Journal · doi:10.15407/ubj94.02.057 · Cited by 1

Neuroimaging in multiple system atrophy

Tondo, G., Comi, C., Naldi, A., de Natale, E. R., & Politis, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821651-4.00008-7 · Cited by 1

The role of brain noradrenaline in Alzheimer's disease: Implications for a precision medicine-oriented approach

Galgani, A., & Giorgi, F. S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-824010-6.00049-6 · Cited by 1

Conformational changes and the self-assembly of alpha-synuclein

Mason, R. J. A. (2018) · Sheffield Hallam University · doi:10.7190/shu-thesis-00151 · Cited by 1

Iron-induced relaxation mechanisms in the human substantia nigra: Towards quantifying iron load in dopaminergic neurons

Brammerloh, M., Weigelt, I., Arendt, T., Gavriilidis, F., Scherf, N., Jankuhn, S., Morawski, M., Weiskopf, N., & Kirilina, E. P. (2018) · MPG.PuRe (Max Planck Society) · Cited by 1

Erythropoietin as a Modulator of Pathology in a Toxicant Mouse Model of Parkinson’s Disease

Thompson, A. (2019) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2019-13782 · Cited by 1

Neurobiological Alterations Of The Substantia Nigra In Sudden Infant Death SyndromePreprint

Lavezzi, A. M., Mehboob, R., Alfonsi, G., & Ferrero, S. (2020) · doi:10.21203/rs.2.24091/v1 · Cited by 1

Neuronal hemoglobin induces loss of dopaminergic neurons in mouse Substantia nigra, cognitive deficits and cleavage of endogenous α-synucleinPreprint

Chiara, S., Bon, C., Cecco, E. D., Marta, C., Narkiewicz, J., Pietro, P., Perissinotto, F., Claudio, S., Francesca, P., Giuseppe, L., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.13.464204 · Cited by 1

Effects of BMP signalling in regulation of melanogenesis, pigment transfer and melanocyte migration

Lim, J. (2021) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/154779

Modulating the aggregation of alpha-synuclein and prion protein with small molecules.

Fonseca‐Ornelas, L. (2016) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5964 · Cited by 1

Fronto-striato-thalamic circuit connectivity and neuromelanin in schizophrenia: an fMRI and neuromelanin-MRI studyPreprint

Kwon, J. S., Choi, S., Kim, M., Kim, T., Choi, E., Lee, J., Moon, S. Y., Cho, S. S., & Lee, J. (2023) · Research Square · doi:10.21203/rs.3.rs-2725867/v1 · Cited by 1

Inversed association of locus coeruleus MRI integrity with structural volume and its impact on individual’s inattentivenessPreprint

Neal, J., Kim, S. H., Katz, B., Kim, I. H., & Lee, T. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.27.614628 · Cited by 1

Developmental variation in dopamine neurobiology, neurocognitive functioning, and impulsivity shape substance use trajectories in youthPreprint

Parr, A. C., Ojha, A., Petrie, D. J., Calabro, F. J., Tervo‐Clemmens, B., Foran, W., FitzGerald, D., Tapert, S. F., Nooner, K. B., Thompson, W. K., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.24.684358 · Cited by 1

Impact of Alzheimer’s disease risk factors and local neuromelanin content on the transcriptomic landscape of the human locus coeruleusPreprint

Mulvey, B., Divecha, H. R., Tippani, M., Bach, S. V., Bharadwaj, R. A., Rosario, I. D., Maguire, S. E., Miller, R. A., Salisbury, A. J., Chandra, A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.29.685354 · Cited by 1

Biofluid-based Biomarkers for Parkinsons Disease: A New Paradigm

Khoo, S. K. (2015) · AIMS Medical Science · doi:10.3934/medsci.2015.4.371

Estudo dos efeitos da superexpressão da alfa-sinucleína sobre o tráfego mitocondrial e autofagia em leveduras, células SH-SY5Y e neurônios dopaminérgicos derivados de hiPSC de pacientes com doença de Parkinson

Melo, T. Q. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2017.tde-01032017-131637

The development of affective and cognitive striatal neurobiology and connectivity during adolescence

Larsen, B. (2018) · D-Scholarship@Pitt (University of Pittsburgh)

Differentiating the Substantia Nigra and Ventral Tegmental Area in Early-stage Parkinson's Disease Using Iron Imaging

Alushaj, E. (2019) · Scholarship@Western (Western University)

Age-Related Iron Deposition in the Deep Brain Structures of Normal Subjects: A Post-Mortem 7.0-Tesla Magnetic Resonance Study

2, U. D. L., Reuck, J. D., Durieux, N., Cordonnier, C., Bordet, R., Leys, D., Pasquier, F., Auger, F., Maurage, C., & Deramecourt, V. (2019) · Acta Scientific Neurology · doi:10.31080/asne.2019.02.0092

Pick the Company 企業紹介(第76回 2)株式会社TV・ポータル

平田, 和., & 武居, 邦. (2010) · 衛星&ケーブルテレビ

Development of analytical tools to enrich and identify protein dopaminylation

Myers, E. J. (2020) · ResearchWorks at the University of Washington (University of Washington)

Altered Cerebral Iron Over the Whole Brain in Chronic Migraine Using Voxel-Based Quantitative Susceptibility MappingPreprint

Chen, Z., Dai, W., Chen, X., Liu, M., Ma, L., & Yu, S. (2020) · Research Square · doi:10.21203/rs.3.rs-126678/v1

Recapitulating Parkinson’s disease pathology in a three-dimensional neural cell culture model

Taylor-Whiteley, T. R. (2019) · Sheffield Hallam University · doi:10.7190/shu-thesis-00321

Análise comparativa de neurônios derivados de células-tronco pluripotentes induzidas (iPSC) para avaliar a associação da Doença de Gaucher e Doença de Parkinson

de Araújo, F. T. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.41.2020.tde-15062020-162144

Improved Reproducibility of Protein Detection in Neuromelanin-containing Human Substantia Nigra Tissue enriched by Laser MicrodissectionPreprint

Kösters, S., Rettel, M., Eggers, B., Riederer, P. F., Gerlach, M., Savitski, M. M., Marcus, K., & May, C. (2020) · doi:10.21203/rs.3.rs-70905/v1

Nanocomposites made from nanoporous cellulose fibre

Svensson, A. (2012) · KTH Publication Database DiVA (KTH Royal Institute of Technology)

Dopamine and L-Dopa as Selective Endogenous Neurotoxins

Segura‐Aguilar, J., Ahumada-Castro, U., & Paris, I. B. (2021) · Springer eBooks · doi:10.1007/978-3-030-71519-9_70-1

Neuromelanin can protect against iron‐mediated oxidative damage in system modeling iron overload of brain aging and Parkinson’s disease

Zecca, L., Casella, L., Albertini, A., Bellei, C., Zucca, F. A., Engelen, M., Żądło, A. C., Szewczyk, G. M., Zaręba, M., & Sarna, T. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05541.x · Cited by 233

Single-cell quantification of the iron-neuromelanin balance in dopaminergic neurons across the lifespanPreprint

Büttner, F., Reinert, T., Jäger, C., Brammerloh, M., Morawski, M., Lipp, I., Falkenberg, G., Brückner, D., McElreath, R., Crockford, C., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.08.721830

Neuromelanin and its interaction with iron as a potential risk factor for dopaminergic neurodegeneration underlying Parkinson's disease

Gerlach, M., Double, K. L., Ben‐Shachar, D., Zecca, L., Youdim, M. B. H., & Riederer, P. F. (2003) · Neurotoxicity Research · doi:10.1007/bf03033371 · Cited by 112

The enigma of neuromelanin in Parkinson's disease substantia nigra.

Youdim, M. B. H., Ben‐Shachar, D., & Riederer, P. F. (1994) · PubMed · Cited by 70

Iron as catalyst for oxidative stress in the pathogenesis of Parkinson's disease?

Kienzl, E., Jellinger, K. A., Stachelberger, H., & Linert, W. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00458-0 · Cited by 62